Want to see SE:CRED.A full AI Analyst Report?
Top Page
Creades AB
(CRED.A)
Select Model
Select Model
Rating:77Outperform
Price Target:
kr104.00
▲(22.28% Upside)
Action:Reiterated
Date:07/18/26
The score is driven primarily by a strong financial foundation (ultra-low leverage and positive cash flow) despite volatile revenue/margins typical of investment-driven results. Technicals are supportive with price above key moving averages and positive MACD, though near-term indicators look stretched. Valuation is an additional positive, with a very low P/E and a modest dividend yield.
Positive Factors
Conservative Balance Sheet
Negligible debt and substantial equity provide durable financial flexibility. This capital structure reduces solvency risk, enables opportunistic deployments during market dislocations, and supports long-term active ownership and governance without being constrained by interest or refinancing pressures.
Negative Factors
Earnings Visibility
Revenue and margins swing materially year-to-year due to market-driven investment results and revaluations. This undermines predictability of distributable earnings and complicates multi-quarter planning, making forecasting of dividends and capital allocation outcomes less reliable for investors.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative Balance Sheet
Negligible debt and substantial equity provide durable financial flexibility. This capital structure reduces solvency risk, enables opportunistic deployments during market dislocations, and supports long-term active ownership and governance without being constrained by interest or refinancing pressures.
Read all positive factors
Creades AB (CRED.A) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr12.55B
Dividend Yield1.76%
Average Volume (3M)101.70K
Price to Earnings (P/E)5.3
Beta (1Y)1.18
Revenue Growth31.65%
EPS Growth87.59%
CountrySE
Employees7
SectorGeneral
Sector StrengthN/A
IndustryAsset Management
Share Statistics
EPS (TTM)17.26
Shares Outstanding93,103,640
10 Day Avg. Volume119,742
30 Day Avg. Volume101,699
Financial Highlights & Ratios
PEG Ratio9.26
Price to Book (P/B)0.91
Price to Sales (P/S)7.81
P/FCF Ratio79.28
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Creades AB Business Overview & Revenue Model
Company Description
Established in 2011 and headquartered in Stockholm, Sweden, Creades AB operates as an investment entity focused on both private equity and venture capital. The firm's mandate is broad, covering the entire lifecycle of companies from nascent seed a...
How the Company Makes Money
Creades makes money primarily from the financial performance of its investment portfolio. Its key earnings drivers are: (1) dividends and other distributions received from portfolio companies; (2) realized capital gains when it sells all or part o...
Creades AB Financial Statement Overview
Summary
Income Statement
54
Neutral
Balance Sheet
87
Very Positive
Cash Flow
71
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | -7.00M | 1.30B | 1.28B | 538.00M | -4.19B | 4.47B |
| Gross Profit | -27.00M | 1.27B | 1.27B | 538.00M | -4.19B | 4.47B |
| EBITDA | 2.34B | 1.21B | 1.20B | 560.00M | -3.96B | 4.22B |
| Net Income | 2.34B | 1.21B | 1.20B | 558.00M | -3.95B | 4.19B |
Balance Sheet | ||||||
| Total Assets | 13.15B | 11.25B | 10.31B | 9.32B | 9.05B | 13.52B |
| Cash, Cash Equivalents and Short-Term Investments | 134.00M | 287.00M | 717.00M | 299.00M | 613.00M | 467.00M |
| Total Debt | 7.00M | 8.00M | 10.00M | 2.00M | 3.00M | 6.00M |
| Total Liabilities | 307.00M | 95.00M | 153.00M | 147.00M | 245.00M | 575.00M |
| Stockholders Equity | 12.85B | 11.15B | 10.16B | 9.18B | 8.81B | 12.95B |
Cash Flow | ||||||
| Free Cash Flow | 201.00M | 128.00M | 190.00M | 205.00M | 25.00M | 89.00M |
| Operating Cash Flow | 201.00M | 128.00M | 190.00M | 205.00M | 25.00M | 89.00M |
| Investing Cash Flow | -571.00M | -341.00M | 438.00M | -329.00M | 311.00M | -1.07B |
| Financing Cash Flow | -216.00M | -217.00M | -210.00M | -190.00M | -190.00M | 805.00M |
Creades AB Technical Analysis
Positive
85.05
Price Trends
82.14
Positive
77.22
Positive
74.03
Positive
Market Momentum
2.69
Negative
74.02
Negative
73.84
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:CRED.A, the sentiment is Positive. The current price of 85.05 is below the 20-day moving average (MA) of 86.63, above the 50-day MA of 82.14, and above the 200-day MA of 74.03, indicating a bullish trend. The MACD of 2.69 indicates Negative momentum. The RSI at 74.02 is Negative, neither overbought nor oversold. The STOCH value of 73.84 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:CRED.A.
Creades AB Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | kr12.55B | 5.28 | 20.54% | 1.88% | 31.65% | 87.59% | |
75 Outperform | kr6.33B | 8.94 | ― | 5.22% | -9.14% | 1.57% | |
72 Outperform | kr8.23B | 34.35 | 16.15% | ― | 18.53% | 20.60% | |
63 Neutral | kr20.85B | -5.38 | -19.39% | 1.03% | 8.76% | -3392.98% | |
61 Neutral | kr12.22B | -108.76 | -0.81% | 3.70% | -33.02% | -140.00% | |
58 Neutral | kr5.96B | -76.03 | -1.33% | 0.79% | 78.30% | 62.60% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
SE:CRED.A
Creades AB
91.10
14.42
18.80%
SE:RATO.B
Ratos AB
36.98
3.18
9.41%
SE:BURE
Bure Equity AB
277.00
0.84
0.30%
SE:SVOL.B
Svolder AB Class B
55.50
2.76
5.23%
SE:MCAP
MedCap AB
551.00
-102.00
-15.62%
SE:ORES
Investment AB Oresund
138.60
23.21
20.11%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.